IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)
ADNEXUS THERAPEUTICS, INC. has filed to come public via an IPO with the filed amount to sell up to $86,250,000 in common stock. Adnexus has taken the proposed ADNX ticker ...Read Full Story »

